No results for ‘’
Shilpa Medicare Ltd
₹928.55
(4.37%)
Wed, 09 Sept 2026, 03:26 am
Health Technology
Pharmaceuticals: Major
24.5KShilpa Medicare Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 30.10 | 16.69 | 14.42 | 0 | 13.76 | 12.39 | 13.86 | 12.73 | 21.03 | 51.60 | 31.83 | 46.04 | 35.58 | 24.71 | 12.77 | 18.41 | 56.83 | 0 | 125.64 | 82.51 |
| Price to book ratio | 4.05 | 2.83 | 2.30 | 1.34 | 5.82 | 2.81 | 2.14 | 1.89 | 3.85 | 7.02 | 5.16 | 5.16 | 3.49 | 2.32 | 1.50 | 1.84 | 1.89 | 1.12 | 2.21 | 2.73 |
| Price to sales ratio | 2.50 | 1.75 | 1.65 | 0.47 | 2.21 | 2.11 | 1.81 | 1.62 | 2.78 | 6.19 | 4.65 | 6.36 | 4.86 | 3.85 | 2.22 | 3.02 | 3.02 | 1.91 | 3.48 | 5.03 |
| Price to cash flow ratio | 0 | 13.78 | 21.56 | 3.24 | 12.15 | 13.86 | 9.71 | 13.55 | 22.70 | 56.46 | 26.06 | 132.76 | 81.44 | 19.04 | 15.98 | 98.92 | 51.63 | 16.08 | 87.66 | 101.72 |
| Enterprise value | 113Cr | 118Cr | 231Cr | 187Cr | 661Cr | 584Cr | 572Cr | 662Cr | 1706Cr | 3920Cr | 3357Cr | 4866Cr | 3737Cr | 2865Cr | 2332Cr | 3433Cr | 4085Cr | 2758Cr | 4901Cr | 7010Cr |
| Enterprise value to EBITDA ratio | 16.54 | 11.85 | 12.45 | 5.83 | 8.68 | 8.32 | 8.99 | 9.71 | 13.99 | 30.96 | 20.79 | 29.25 | 27.64 | 19.69 | 10.93 | 19.64 | 20.73 | 32.13 | 20.60 | 22.74 |
| Debt to equity ratio | 0.06 | 0.18 | 1.58 | 1.92 | 0.77 | 0.26 | 0.22 | 0.41 | 0.32 | 0.35 | 0.14 | 0.24 | 0.18 | 0.16 | 0.29 | 0.57 | 0.37 | 0.45 | 0.52 | 0.25 |
| Return on equity % | 0 | 18.47 | 22.35 | -1.82 | 53.45 | 30.38 | 16.63 | 15.96 | 21.25 | 15.70 | 17.70 | 13.23 | 10.16 | 9.84 | 12.36 | 10.53 | 3.68 | -1.80 | 1.77 | 3.75 |
Shilpa Medicare Ltd Enterprise Value
The Shilpa Medicare Ltd Enterprise Value is a key financial metric used by investors to evaluate Shilpa Medicare Ltd's valuation, profitability, and overall financial performance. Tracking the Shilpa Medicare Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Shilpa Medicare Ltd (NSE: SHILPAMED, BSE: 530549) is currently trading at ₹928.55, with a market capitalization of ₹18581.25Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Shilpa Medicare Ltd Enterprise Value is essential for fundamental analysis.
Shilpa Medicare Ltd Enterprise Value Current Value
The current Shilpa Medicare Ltd Enterprise Value stands at 7010Cr.
The latest Shilpa Medicare Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Shilpa Medicare Ltd Enterprise Value Historical Trend
The Shilpa Medicare Ltd Enterprise Value has shown the following historical trend:
- 2024: 7010Cr
- 2023: 4901Cr
- 2022: 2758Cr
- 2021: 4085Cr
- 2020: 3433Cr
The recent rise in Shilpa Medicare Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Shilpa Medicare Ltd Enterprise Value Indicates for Investors
The Shilpa Medicare Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Shilpa Medicare Ltd.
Shilpa Medicare Ltd Enterprise Value Analysis Summary
The Shilpa Medicare Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Shilpa Medicare Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Shilpa Medicare Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.